Powerock Pharma Tesofensine 250 mcg 100 caps. 25 000 mg
TESOFENSINE revolutionizes appetite control and intensifies metabolism by modulating three key neurotransmitters – it increases energy expenditure and supports weight reduction. Choose Powerock Pharma for guaranteed purity ≥99.9% and proven research results.
TESOFENSINE 25,000 mg
TESOFENSINE (tesofensine hydrochloride) is an advanced neurochemical compound for research on effective body weight control and appetite suppression. This powerful research reagent has been designed for precise studies on weight management and metabolic disorders. Its action is based on the modulation of neurotransmitter levels in the central nervous system, leading to reduced hunger sensation and increased energy expenditure. This unique functionality makes TESOFENSINE widely used in research on obesity and metabolic syndrome.
TESOFENSINE Powerock Pharma - Properties
Discover the potential laboratory properties of TESOFENSINE, which may support research on weight control, metabolism, and neurological functions.
Body Weight Reduction
Supports significant weight loss by modulating neurotransmitters.
Appetite Suppression
Shows the ability to significantly reduce hunger sensation in research models.
Metabolism Enhancement
Increases basal metabolic rate through nervous system activation.
Triple Mechanism
Inhibits the reuptake of dopamine, norepinephrine, and serotonin simultaneously.
Energy Level Boost
Raises overall energy levels without typical stimulating effects.
Mood Stability
Positively affects mood regulation through serotonin modulation.
Highest Purity
HPLC-tested with guaranteed purity ≥99.9% for reliable results.
Precise Action
Targeted action on neurotransmitter receptors for optimal results.
How tesofensine works
- Triple inhibition mechanism: Tesofensine acts by inhibiting the reuptake of dopamine, norepinephrine, and serotonin—three key neurotransmitters regulating appetite, mood, and metabolic rate.
- Increased synaptic availability: By increasing the synaptic availability of these neurotransmitters, tesofensine leads to a marked reduction in appetite and an increase in basal metabolic rate.
- No direct stimulating effects: The unique mechanism provides effective weight management without the direct stimulating effects associated with traditional appetite suppressants.
- Reward system modulation: Influences dopaminergic pathways associated with the reward system, which can affect eating behaviors.
- Research potential: Represents a promising candidate for studies on obesity, metabolic syndrome, and eating disorders.
Why choose TESOFENSINE from Powerock Pharma?
At Powerock Pharma, our priority is to provide only the highest quality research substances. Each batch of Tesofensine is manufactured in facilities compliant with GMP, HACCP, and ISO 13485 standards. Our strict quality control supervision and use of state-of-the-art HPLC testing procedures ensure not only product efficacy but also their safety and reliability with a purity guarantee of ≥99.9%. We collaborate with leading laboratories to ensure the purity and effectiveness of the substances, providing durable and repeatable results. By choosing Powerock Pharma, you are opting for excellence, safety, and unmatched quality in research materials.
Research Protocol
How to research:
Tesofensine (tesofensine hydrochloride) should be administered orally in the form of prefabricated 250 mg capsules, according to the specific dosing schedule in the research protocol.
When to administer:
To achieve optimal consistency of research results, it is recommended to administer at the same time each day. This helps maintain stable plasma levels and reliable data collection.
Single cycle duration:
The recommended research cycle is 8–12 weeks. This duration allows for comprehensive observation of Tesofensine's effects on appetite, metabolism, and related parameters.
Recommended amount for model A:
In studies using model type A, a lower initial dose is recommended—usually 50–100 mg per administration. Adjust according to observed results and tolerance.
Recommended amount for model B:
For model type B, an initial dose of 100–250 mg per administration is usually used. The dose may be modified according to research goals and model response.
Monitoring:
Continuous monitoring of all research models is essential. Record physiological responses, changes in appetite, mood, and any adverse effects throughout the study period.
Frequently Asked Questions
- Typical research doses range from 50 mg to 250 mg per administration, depending on the model type and research goals. Always follow the specific protocol for your studies.
- Yes, Tesofensine is often combined with compounds such as Yohimbine HCl, L-Carnitine, or Alpha GPC to target specific research outcomes such as fat loss, endurance, or cognitive enhancement.
- Some models may exhibit dry mouth, insomnia, mild increase in heart rate, or mood changes. Continuous monitoring is recommended for prompt response to any adverse effects.
- Data on long-term safety are limited. For best practices, use within the recommended cycle lengths (8–12 weeks) and carefully monitor models for any adverse reactions.
- Store at 25°C or below, protect from light and moisture, in a cool, dry, and dark place to maintain stability and effectiveness.
- Powerock Pharma ensures that each batch meets or exceeds GMP, HACCP, and ISO 13485 standards, with HPLC-tested purity (≥99.9%) and rigorous quality controls—delivering consistent, high-quality results for your research.
Calculator for measuring research doses
Tip: 1 MG = 1000 MCG